Skip to main content

Emeriti Faculty



Joel G. Hardman

Chair 1975-1990

Joel G. Hardman served as Chair of the Department of Pharmacology from 1975-1990, establishing the department as a premier place for research and training in pharmacology.  A major reason for the success of the Training Program in Pharmacological Sciences was Dr. Hardman’s personal involvement in the mentoring of each graduate student.  He expected each student to perform at their best and created an intellectual environment that fostered the scientific growth and critical thought of students, postdoctoral fellows and faculty colleagues.

Joel G. Hardman received his Ph.D. degree in Pharmacology from Emory University in 1964.  He came to Vanderbilt to be a postdoctoral fellow with Earl Sutherland.  After his early work on cyclic AMP as a second messenger, carried out in Sutherland’s laboratory, Dr. Hardman went on to discover guanylate cyclase, the enzyme responsible for synthesizing cyclic GMP from GTP. This discovery led to the appreciation that cGMP, like cAMP, can serve as an intracellular second messenger.  He rose through the ranks to become Professor of Physiology in 1972.  His creative and incisive mind, which contributed to his discoveries, also served him well in his role as teacher and mentor.  In 1975, he was appointed as Chair of Pharmacology, and in 1991 was named Associate Vice-Chancellor for Health Affairs.

Dr. Hardman is internationally recognized as an outstanding scientist, educator and administrator.  In 1992, Dr. Hardman became Co-Editor-In-Chief of the major text in Pharmacology, Goodman and Gilman’s The Pharmacological Basis of Therapeutics, which is published in many languages worldwide.  He served as President of the American Society for Pharmacology and Experimental Therapeutics in 1993/1994.

The graduate students in Pharmacology named this, their annual forum, the Joel G. Hardman Student-Invited Pharmacology Forum, in recognition of Dr. Hardman’s sustained interest in the training of young scientists.

    Erwin J. Landon, M.D., Ph.D.

    Associate Professor, Emeritus, Pharmacology

      Peter W. Reed, Ph.D.

      Associate Professor, Emeritus, Pharmacology

        L. Jack Roberts, Ph.D.

        Professor, Emeritus, Pharmacology


          Elaine Sanders-Bush

          Interim Chair 1999-2000

          Born and raised on a small farm in Kentucky, Elaine Sanders-Bush attended Western Kentucky University in Bowling Green, where a visiting professor in Pharmacology fromVanderbilt University introduced her to the excitement of scientific research and the significant opportunities made available by advanced training. Upon graduation with a B.S. in Biology and Chemistry, she joined the graduate program in Pharmacology at Vanderbilt in 1962 and earned a Ph.D. degree in Pharmacology in 1967. After postdoctoral training, she joined the Vanderbilt faculty in 1969, where she remained until her retirement in 2010, interrupted only by brief sabbaticals at the Karolinska Institute in Stockholm and Stanford University. Her service locally and nationally has been transformative.  In 2006, she was elected President of the American Society for Pharmacology and Experimental Therapeutics. In that year, she was also named the Harvie Branscomb Distinguished Professor atVanderbilt University.

          Dr. Sanders-Bush’s research has made major contributions to the understanding of serotonin and its receptors, from pharmacology and signal transduction to in vivo brain function. Her research interest in serotonin dates back to her graduate school days studying the metabolic inactivation of a hallucinogenic serotonin derivative. Over time, as neuroscience research expanded exponentially, her work evolved to take advantage of the tremendous advances that were offered in molecular biology, genetics and behavior. Her research accomplishments have brought her broad recognition at a national and international level; among her research awards are a Bristol-Myers Squibb Award for Neuroscience Research, a MERIT Award from the National Institute of Mental Health and the Heftner Prize for Outstanding Basic Research.

          Dr. Sanders-Bush has been a leader in the development of neuroscience research and graduate education at Vanderbilt. In 1997, she spearheaded the creation of a new Ph.D. degree program in Neuroscience and served as director of that program until 2008.  During this decade, the program grew to more than sixty graduate students. In 2002, she was appointed the first Director of the Vanderbilt Brain Institute. In recognition of her impact in graduate education at Vanderbilt, the Elaine Sanders-Bush Award for Mentoring Graduate and/or Medical Students in the Research Setting was created in 2006.  Dr. Sanders-Bush has a deep personal commitment to enhancing opportunities for minority trainees and has worked to enhance minority training programs at Tennessee State University, Meharry Medical College, and Vanderbilt. In recognition of her commitment and accomplishments, she was the first recipient of Vanderbilt’s Levi Watkins, Jr., Award for Leadership Diversity in 2002 and, in 2009, the Dr. Dolores C. Shockley Lecture and Partnership Award.

          Over the course of her career, Dr. Sanders-Bush has mentored scores of graduate students and postdoctoral fellows as well as junior faculty. She has a strong record of training students who think both creatively and critically and is recognized for being a nurturing mentor while insisting that her students function at their highest level. Her former trainees hold prominent positions at major U.S. academic centers and in the pharmaceutical industry.

            Jack N. Wells, Ph.D.

            Professor, Emeritus, Pharmacology